Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aristidis Chaidos"'
Autor:
Konstantinos L. Bourantas, Eleni Kapsali, Stavroula Tsiara, Alexandres Chr. Makis, Anestis Mavridis, Eleftheria Hatzimichael, Aristidis Chaidos
Publikováno v:
European Journal of Haematology. 63:19-25
Whereas beta-2-microglobulin (beta2M) has mainly been used as a prognostic factor in patients with lymphoproliferative disorders, some studies have reported the value of beta2M in myeloproliferative disorders (MPD). In order to investigate a potentia
Autor:
C. Zilidis, Bourantas Kl, Alexandros Makis, I. Bouba, Ioannis Georgiou, Aristidis Chaidos, E. Hatzi, V. Kranas
Publikováno v:
European Journal of Haematology. 70:75-78
Objectives : β-Thalassemia is a common autosomal recessive disorder resulting from over 200 different mutations of the β-globin genes. The spectrum of β-thalassemia mutations in Greece has been previously described in the population of the capital
Autor:
Konstantinos L. Bourantas, Stavroula Tsiara, Eleftheria Hatzimichael, Aristidis Chaidos, Leonidas Christou
Publikováno v:
European Journal of Haematology. 67:51-53
Primary plasma cell (PCL) leukemia is a rare lymphoproliferative disorder characterized by a malignant proliferation of plasma cells in the bone marrow and peripheral blood. Survival with standard therapy using melphalan is very poor. Doxorubicin enc
Autor:
Konstantinos L. Bourantas, Alexandres Chr. Makis, Anestis Mavridis, Aristidis Chaidos, Georgios N. Dalekos, Stavroula Tsiara
To identify a possible acute phase response during the steady state of sickle cell disease, we estimated the serum alterations of acute phase proteins, beta2-microglobulin (beta2M), kappa and lambda light chains, interleukins (ILs) and tumor necrosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c028adf6ec6344b16f752737abc8ad86
http://olympias.lib.uoi.gr/jspui/handle/123456789/24088
http://olympias.lib.uoi.gr/jspui/handle/123456789/24088